|
TCEAL8 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.272800E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.718000E-02 |
| Normal-vs-Stage2 |
5.012400E-01 |
| Normal-vs-Stage3 |
8.866400E-01 |
| Normal-vs-Stage4 |
3.471700E-02 |
| Stage1-vs-Stage2 |
6.603800E-02 |
| Stage1-vs-Stage3 |
1.434150E-01 |
| Stage1-vs-Stage4 |
5.554200E-04 |
| Stage2-vs-Stage3 |
6.022200E-01 |
| Stage2-vs-Stage4 |
4.197800E-01 |
| Stage3-vs-Stage4 |
9.019900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.998800E-01 |
| Normal-vs-AfricanAmerican |
1.583360E-01 |
| Normal-vs-Asian |
5.431800E-02 |
| Caucasian-vs-AfricanAmerican |
5.845500E-02 |
| Caucasian-vs-Asian |
1.923390E-01 |
| AfricanAmerican-vs-Asian |
3.536000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.042800E-01 |
| Normal-vs-Female |
4.817200E-01 |
| Male-vs-Female |
3.677600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.998400E-01 |
| Normal-vs-Age(41-60Yrs) |
5.345400E-01 |
| Normal-vs-Age(61-80Yrs) |
9.040400E-01 |
| Normal-vs-Age(81-100Yrs) |
6.599800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.760000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.543200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.172000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.301800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.994800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.927800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.125700E-02 |
| Normal-vs-Grade 2 |
1.462240E-02 |
| Normal-vs-Grade 3 |
2.346400E-01 |
| Normal-vs-Grade 4 |
9.921300E-03 |
| Grade 1-vs-Grade 2 |
4.421200E-01 |
| Grade 1-vs-Grade 3 |
6.619300E-03 |
| Grade 1-vs-Grade 4 |
4.939200E-03 |
| Grade 2-vs-Grade 3 |
1.792380E-04 |
| Grade 2-vs-Grade 4 |
4.03309999996715E-06 |
| Grade 3-vs-Grade 4 |
8.360000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
9.626200E-04 |
| Normal-vs-ccB subtype |
1.535030E-01 |
| ccA subtype-vs-ccB subtype |
2.93900000003511E-06 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.485800E-01 |
| Normal-vs-N1 |
3.321300E-03 |
| N0-vs-N1 |
4.447800E-02 |
|
|
